Breaking News
Mixed Results With Metformin in Men Taking ADT for Prostate Cancer

(MedPage Today) — Metformin failed to prevent metabolic syndrome in men receiving hormone therapy for prostate cancer, but improved risk factors associated with the syndrome, an abbreviated randomized trial showed. The proportion of patients affected…
:max_bytes(150000):strip_icc()/Health-GettyImages-1140755784-0edebc1dfc3647c79b057bccbb7be393.jpg?w=390&resize=390,220&ssl=1)


